The new FDA commissioner Scott Gottlieb is quietly and persistently revamping the FDA to make it easier for drug and device companies to get their products on the market. The news, which is being welcomed by industry, also almost certainly means that more people will be exposed to weak, ineffective, or dangerous products. Gottlieb’s entire ...
FDAs Gottlieb preparing to lower the bar to approval
By Larry Husten
4 Oct 2017